was doing some catch up reading last night, came across this http://effectivehealthcare.ahrq.gov/...col-140721.pdf
looks like Cxbladder has a few more competitors than I thought (There are five diagnostic biomarker tests approved by the FDA for diagnosis or surveillance of bladder cancer: BTAstat® (BTA), Alere NMP22®, BladderChek® (NMP22), UroVysion® (FISH) and ImmunoCyt™), does anyone know how extensive these tests are used in the US, or how well performance wise these tests are?